Printer Friendly

JACOBS RESIGNS FROM GENETICS INSTITUTE BOARD OF DIRECTORS

 JACOBS RESIGNS FROM GENETICS INSTITUTE BOARD OF DIRECTORS
 CAMBRIDGE, Mass., Aug. 11 /PRNewswire/ -- Genetics Institute, Inc. (NASDAQ: GENIZ) announced today that Dr. Joseph J. Jacobs has resigned from the company's board of directors. Jacobs, an early investor in the company, has served on the board since 1982. Jacobs also serves as the chairman of the board and CEO of Jacobs Engineering, Inc. a firm which he founded.
 "Dr. Jacobs' expertise in the areas of manufacturing, construction and business has been a tremendous asset for us as we have built our organization over the past decade. We appreciate his many contributions to the growth and success of our company," said Gabriel Schmergel, president and CEO of Genetics Institute.
 Genetics Institute is a leading biopharmaceutical firm engaged in the discovery and development of human pharmaceuticals through recombinant DNA and other technologies. The company has a diversified portfolio of licensed and proprietary pharmaceutical products at various stages of development, including treatments for anemia, hemophilia, cancer, infectious diseases, bone damage, heart disease, inflammatory conditions and immune system disorders.
 -0- 8/11/92
 /CONTACT: Melinda Lindquist or Gina Price of Genetics Institute, 617-876-1170/
 (GENIZ) CO: Genetics Institute ST: Massachusetts IN: MTC SU: PER


TM -- NE013 -- 9041 08/11/92 14:29 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 11, 1992
Words:207
Previous Article:GENERAL COMPUTER AWARDED CONTRACT BY EMPLOYEE BENEFIT PLANS, INC. TO PROCESS 7-8 MILLION CLAIMS ANNUALLY
Next Article:UNIQUE OUTDOOR ADVERTISING AT JFK AIRPORT
Topics:


Related Articles
GENETICS INSTITUTE SHARES NOW TRADING UNDER NEW NASDAQ SYMBOL -- GENIZ
GENETICS INSTITUTE AND SCIGENICS RECEIVE FDA GO AHEAD ON M-CSF CHOLESTEROL STUDY
JACOBS CONSTRUCTS ADDITIONS TO GENETICS INSTITUTE FACILITIES
PATRICK GAGE, PH.D. TO BECOME GENETICS INSTITUTE'S CHIEF OPERATING OFFICER; OTHER OFFICERS APPOINTED
GENETICS INSTITUTE ANNOUNCES OFFICER CHANGES
GENETICS INSTITUTE PROPOSES ACQUISITION OF SCIGENICS
SCIGENICS SIGNS DEFINITIVE MERGER AGREEMENT WITH GENETICS INSTITUTE
BENNO C. SCHMIDT RETIRES AS GENETICS INSTITUTE'S CHAIRMAN OF THE BOARD
L. Patrick Gage, Ph.D., Joins Protein Design Labs' Board of Directors.
Interleukin Genetics Expands Its Board of Directors.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters